{"id":"https://openalex.org/W2012014689","doi":"https://doi.org/10.1016/s0140-6736(87)90648-9","title":"PREVENTION OF REJECTION OF KIDNEY TRANSPLANTS BY MONOCLONAL ANTIBODY DIRECTED AGAINST INTERLEUKIN 2","display_name":"PREVENTION OF REJECTION OF KIDNEY TRANSPLANTS BY MONOCLONAL ANTIBODY DIRECTED AGAINST INTERLEUKIN 2","publication_year":1987,"publication_date":"1987-06-01","ids":{"openalex":"https://openalex.org/W2012014689","doi":"https://doi.org/10.1016/s0140-6736(87)90648-9","mag":"2012014689","pmid":"https://pubmed.ncbi.nlm.nih.gov/2884454"},"language":"en","primary_location":{"id":"doi:10.1016/s0140-6736(87)90648-9","doi":"https://doi.org/10.1016/s0140-6736(87)90648-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0140-6736(87)90648-9","pdf_url":null,"source":{"id":"https://openalex.org/S49861241","display_name":"The Lancet","issn_l":"0099-5355","issn":["0099-5355","0140-6736","1474-547X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065766935","display_name":"Jean\u2010Paul Soulillou","orcid":"https://orcid.org/0000-0001-7468-5135","observed_orcids":["https://orcid.org/0000-0001-7468-5135"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J.P. Soulillou","raw_affiliation_strings":["INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","INSERM Unit 211 ( T Lymphocytes), Nantes, France","Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","and Immunotech, Marseille-Luminy, France","Immunotech, Marseille-Luminy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"INSERM Unit 211 ( T Lymphocytes), Nantes, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]},{"raw_affiliation_string":"and Immunotech, Marseille-Luminy, France","institution_ids":[]},{"raw_affiliation_string":"Immunotech, Marseille-Luminy, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076808011","display_name":"Brigitte Le Mauff","orcid":"https://orcid.org/0000-0001-9242-4895","observed_orcids":["https://orcid.org/0000-0001-9242-4895"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"B. Le Mauff","raw_affiliation_strings":["INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","INSERM Unit 211 ( T Lymphocytes), Nantes, France","Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","and Immunotech, Marseille-Luminy, France","Immunotech, Marseille-Luminy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"INSERM Unit 211 ( T Lymphocytes), Nantes, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]},{"raw_affiliation_string":"and Immunotech, Marseille-Luminy, France","institution_ids":[]},{"raw_affiliation_string":"Immunotech, Marseille-Luminy, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029679351","display_name":"Daniel Olive","orcid":"https://orcid.org/0000-0003-1299-4113","observed_orcids":["https://orcid.org/0000-0003-1299-4113","https://orcid.org/0000-0001-7027-040X"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"D. Olive","raw_affiliation_strings":["INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","INSERM Unit 211 ( T Lymphocytes), Nantes, France","Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","and Immunotech, Marseille-Luminy, France","Immunotech, Marseille-Luminy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"INSERM Unit 211 ( T Lymphocytes), Nantes, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]},{"raw_affiliation_string":"and Immunotech, Marseille-Luminy, France","institution_ids":[]},{"raw_affiliation_string":"Immunotech, Marseille-Luminy, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063987135","display_name":"Michel A. DELAAGE","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Delaage","raw_affiliation_strings":["INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","INSERM Unit 211 ( T Lymphocytes), Nantes, France","Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","and Immunotech, Marseille-Luminy, France","Immunotech, Marseille-Luminy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"INSERM Unit 211 ( T Lymphocytes), Nantes, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]},{"raw_affiliation_string":"and Immunotech, Marseille-Luminy, France","institution_ids":[]},{"raw_affiliation_string":"Immunotech, Marseille-Luminy, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091402333","display_name":"Pierre Peyronnet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. Peyronnet","raw_affiliation_strings":["INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","INSERM Unit 211 ( T Lymphocytes), Nantes, France","Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","and Immunotech, Marseille-Luminy, France","Immunotech, Marseille-Luminy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"INSERM Unit 211 ( T Lymphocytes), Nantes, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]},{"raw_affiliation_string":"and Immunotech, Marseille-Luminy, France","institution_ids":[]},{"raw_affiliation_string":"Immunotech, Marseille-Luminy, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005455170","display_name":"Maryvonne Hourmant","orcid":"https://orcid.org/0000-0001-7925-6831","observed_orcids":["https://orcid.org/0000-0001-7925-6831"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Hourmant","raw_affiliation_strings":["INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","INSERM Unit 211 ( T Lymphocytes), Nantes, France","Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","and Immunotech, Marseille-Luminy, France","Immunotech, Marseille-Luminy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"INSERM Unit 211 ( T Lymphocytes), Nantes, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]},{"raw_affiliation_string":"and Immunotech, Marseille-Luminy, France","institution_ids":[]},{"raw_affiliation_string":"Immunotech, Marseille-Luminy, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032703463","display_name":"Claude E. Mawas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Mawas","raw_affiliation_strings":["INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","INSERM Unit 211 ( T Lymphocytes), Nantes, France","Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","and Immunotech, Marseille-Luminy, France","Immunotech, Marseille-Luminy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"INSERM Unit 211 ( T Lymphocytes), Nantes, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]},{"raw_affiliation_string":"and Immunotech, Marseille-Luminy, France","institution_ids":[]},{"raw_affiliation_string":"Immunotech, Marseille-Luminy, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052078738","display_name":"Michel H. Hirn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Hirn","raw_affiliation_strings":["INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","INSERM Unit 211 ( T Lymphocytes), Nantes, France","Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","and Immunotech, Marseille-Luminy, France","Immunotech, Marseille-Luminy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"INSERM Unit 211 ( T Lymphocytes), Nantes, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]},{"raw_affiliation_string":"and Immunotech, Marseille-Luminy, France","institution_ids":[]},{"raw_affiliation_string":"Immunotech, Marseille-Luminy, France","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110049740","display_name":"Yannick Jacques","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Y. Jacques","raw_affiliation_strings":["INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","INSERM Unit 211 ( T Lymphocytes), Nantes, France","Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","and Immunotech, Marseille-Luminy, France","Immunotech, Marseille-Luminy, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM Unit 119 (Experimental Oncology and Therapy), Canc\u00e9rologie et Th\u00e9rapeutique Exp\u00e9rimentales, Marseille, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"INSERM Unit 211 ( T Lymphocytes), Nantes, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Nephrology and Clinical Immunology Service, Centre Hospitalier Universitaire, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]},{"raw_affiliation_string":"and Immunotech, Marseille-Luminy, France","institution_ids":[]},{"raw_affiliation_string":"Immunotech, Marseille-Luminy, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":7890,"currency":"USD","value_usd":7890},"apc_paid":null,"fwci":22.7112,"has_fulltext":false,"cited_by_count":135,"citation_normalized_percentile":{"value":1.0,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"329","issue":"8546","first_page":"1339","last_page":"1342"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kidney-transplantation","display_name":"kidney transplantation","score":0.9700000286102295},{"id":"https://openalex.org/keywords/transplant-rejection-prevention","display_name":"transplant rejection prevention","score":0.7279999852180481},{"id":"https://openalex.org/keywords/il-2-receptor","display_name":"interleukin-2 receptor","score":0.7940000295639038},{"id":"https://openalex.org/keywords/t-cells","display_name":"T cells","score":0.5759999752044678},{"id":"https://openalex.org/keywords/antithymocyte-globulin","display_name":"antithymocyte globulin","score":0.9229999780654907},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.8040000200271606},{"id":"https://openalex.org/keywords/azathioprine","display_name":"azathioprine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/acute-rejection","display_name":"acute rejection","score":0.531000018119812}],"concepts":[{"id":"https://openalex.org/C2776760755","wikidata":"https://www.wikidata.org/wiki/Q18939","display_name":"Azathioprine","level":3,"score":0.903891384601593},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7929465770721436},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.785589337348938},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5941424369812012},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.540347158908844},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.48742249608039856},{"id":"https://openalex.org/C2780303639","wikidata":"https://www.wikidata.org/wiki/Q740909","display_name":"Kidney transplantation","level":3,"score":0.4803389310836792},{"id":"https://openalex.org/C2780372218","wikidata":"https://www.wikidata.org/wiki/Q417222","display_name":"Methylprednisolone","level":2,"score":0.47301748394966125},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4488813281059265},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.44731032848358154},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.44644829630851746},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44435426592826843},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4359322488307953},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.4353106617927551},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.4154372215270996},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.2273845374584198},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000961","descriptor_name":"Antilymphocyte Serum","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005069","descriptor_name":"Evaluation Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006084","descriptor_name":"Graft Rejection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011971","descriptor_name":"Receptors, Immunologic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015375","descriptor_name":"Receptors, Interleukin-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016030","descriptor_name":"Kidney Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0140-6736(87)90648-9","doi":"https://doi.org/10.1016/s0140-6736(87)90648-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0140-6736(87)90648-9","pdf_url":null,"source":{"id":"https://openalex.org/S49861241","display_name":"The Lancet","issn_l":"0099-5355","issn":["0099-5355","0140-6736","1474-547X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet","raw_type":"journal-article"},{"id":"pmid:2884454","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2884454","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lancet (London, England)","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1565160651","https://openalex.org/W1601717539","https://openalex.org/W1981001323","https://openalex.org/W1986924748","https://openalex.org/W1988368135","https://openalex.org/W1991942320","https://openalex.org/W1993803666","https://openalex.org/W2051962533","https://openalex.org/W2085241754","https://openalex.org/W2096297017","https://openalex.org/W2157953677"],"related_works":["https://openalex.org/W2022193848","https://openalex.org/W1978195383","https://openalex.org/W2332754031","https://openalex.org/W2029463812","https://openalex.org/W3021338887","https://openalex.org/W2071648784","https://openalex.org/W2405377849","https://openalex.org/W2618711604","https://openalex.org/W2416879010","https://openalex.org/W2023748102"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2016-06-24T00:00:00"}